These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28501501)

  • 1. Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
    Arioka M; Takahashi-Yanaga F; Kubo M; Igawa K; Tomooka K; Sasaguri T
    Biochem Pharmacol; 2017 Aug; 138():31-48. PubMed ID: 28501501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
    Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
    J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
    Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-inducing factor-1 suppresses the expression of c-Myc in the human cancer cell lines.
    Jingushi K; Nakamura T; Takahashi-Yanaga F; Matsuzaki E; Watanabe Y; Yoshihara T; Morimoto S; Sasaguri T
    J Pharmacol Sci; 2013; 121(2):103-9. PubMed ID: 23357875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
    Takahashi-Yanaga F; Yoshihara T; Jingushi K; Igawa K; Tomooka K; Watanabe Y; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Sasaguri T
    Biochem Pharmacol; 2014 Jun; 89(3):340-8. PubMed ID: 24670930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis.
    Tetsuo F; Arioka M; Miura K; Kai M; Kubo M; Igawa K; Tomooka K; Takahashi-Yanaga F; Nishimura F; Sasaguri T
    Cancer Sci; 2019 Dec; 110(12):3761-3772. PubMed ID: 31553107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt/GSK-3β/β-catenin pathway in B16BL6 cells.
    Tang L; Yue B; Cheng Y; Yao H; Ma X; Tian Q; Ge L; Liu Z; Han X
    Chem Biol Interact; 2014 Oct; 222():7-17. PubMed ID: 25148938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
    Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
    Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway.
    Yoshihara T; Takahashi-Yanaga F; Shiraishi F; Morimoto S; Watanabe Y; Hirata M; Hoka S; Sasaguri T
    Mol Cancer; 2010 Sep; 9():245. PubMed ID: 20843378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
    Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells.
    Yasmin T; Takahashi-Yanaga F; Mori J; Miwa Y; Hirata M; Watanabe Y; Morimoto S; Sasaguri T
    Biochem Biophys Res Commun; 2005 Dec; 338(2):903-9. PubMed ID: 16243295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
    Zheng L; Pan J
    Curr Cancer Drug Targets; 2018; 18(10):988-998. PubMed ID: 29692251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.
    Takahashi-Yanaga F; Sasaguri T
    J Pharmacol Sci; 2009 Feb; 109(2):179-83. PubMed ID: 19179804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways.
    Hseu YC; Thiyagarajan V; Tsou HT; Lin KY; Chen HJ; Lin CM; Liao JW; Yang HL
    Oncotarget; 2016 Apr; 7(16):22409-26. PubMed ID: 26968952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Gai JQ; Sheng X; Qin JM; Sun K; Zhao W; Ni L
    Int J Oncol; 2016 Jan; 48(1):338-48. PubMed ID: 26648168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway.
    Zhang Y; Wang CP; Ding XX; Wang N; Ma F; Jiang JH; Wang QD; Chang JB
    Asian Pac J Cancer Prev; 2014; 15(16):6829-35. PubMed ID: 25169533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
    Wang Y; Liu M; Jin Y; Jiang S; Pan J
    Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halogen-Substituted Derivatives of
    Totsuka K; Makioka Y; Iizumi K; Takahashi K; Oshima Y; Kikuchi H; Kubohara Y
    Biomolecules; 2019 Jun; 9(7):. PubMed ID: 31261818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.